المؤلفون: Kris Berg, Marlene Z. Cohen, Carol H Pullen, Sheri A Rowland, Paula Schulz, Kevin A. Kupzyk, Bernice C. Yates

المصدر: Workplace Health Saf

مصطلحات موضوعية: Adult, medicine.medical_specialty, Nursing (miscellaneous), Physical activity, Pilot Projects, Health Promotion, 030204 cardiovascular system & hematology, Article, Peer Group, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Intervention (counseling), Humans, Medicine, 030212 general & internal medicine, Peer modeling, Exercise, Occupational Health, Framingham Risk Score, Triglyceride, business.industry, Multilevel model, Public Health, Environmental and Occupational Health, Middle Aged, chemistry, Physical therapy, Feasibility Studies, Female, Health information, Exercise prescription, business, Program Evaluation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbf2238a09d184b155e1e45355beda84Test
https://doi.org/10.1177/2165079917753690Test

المؤلفون: Julie C. Yates, Jørgen Vestbo, Robert D. Brook, Natacha Gallot, Robert A. Wise, Peter M.A. Calverley, Fernando J. Martinez, David E. Newby, Bartolome R. Celli, Sally Kilbride, Julie A. Anderson, Courtney Crim

المصدر: American Journal of Respiratory and Critical Care Medicine. 197:47-55

مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Spirometry, medicine.medical_specialty, Internationality, Chlorobenzenes, Critical Care and Intensive Care Medicine, Placebo, Severity of Illness Index, Drug Administration Schedule, Fluticasone propionate, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Reference Values, Forced Expiratory Volume, Internal medicine, medicine, Humans, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Benzyl Alcohols, Aged, Fluticasone, COPD, Dose-Response Relationship, Drug, medicine.diagnostic_test, business.industry, Middle Aged, Prognosis, medicine.disease, Fluticasone furoate/vilanterol, Treatment Outcome, 030228 respiratory system, chemistry, Cardiovascular Diseases, Anesthesia, Drug Therapy, Combination, Female, Vilanterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720786e2f84d3441dd0877271990bf1cTest
https://doi.org/10.1164/rccm.201610-2086ocTest

المؤلفون: Philip D Adamson, Julie C. Yates, Jørgen Vestbo, Fernando J. Martinez, David E. Newby, Nicholas L. Mills, Nicholas J. Cowans, Julie A. Anderson, Bartolome R. Celli, Peter M.A. Calverley, Courtney Crim, Ian J. Dixon, Robert D. Brook

المصدر: Journal of the American College of Cardiology
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Adamson, P D, Anderson, J A, Brook, R D, Calverley, P M A, Celli, B R, Cowans, N J, Crim, C, Dixon, I J, Martinez, F J, Newby, D E, Vestbo, J, Yates, J C & Mills, N L 2018, ' Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease ', Journal of the American College of Cardiology, vol. 72, no. 10, pp. 1126-1137 . https://doi.org/10.1016/j.jacc.2018.06.051Test
Adamson, P D, Anderson, J A, Brook, R D, Calverley, P M A, Celli, B R, Cowans, N J, Crim, C, Dixon, I J, Martinez, F J, Newby, D E, Vestbo, J, Yates, J C & Mills, N L 2018, ' Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease ' vol. 72, no. 10, pp. 1126-1137 . DOI: 10.1016/j.jacc.2018.06.051

مصطلحات موضوعية: Male, Lydia Becker Institute, Disease, ICS, inhaled corticosteroid, 030204 cardiovascular system & hematology, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, LABA, long-acting beta-agonist, 0302 clinical medicine, Randomized controlled trial, Limit of Detection, law, Prospective Studies, 030212 general & internal medicine, COPD, CV, cardiovascular, Middle Aged, Bronchodilator Agents, Cardiovascular Diseases, Cardiology, Female, Vilanterol, Cardiology and Cardiovascular Medicine, medicine.drug, Risk, cardiovascular risk, medicine.medical_specialty, Cardiac troponin, Chlorobenzenes, Placebo, Fluticasone propionate, Article, chronic obstructive pulmonary disease, 03 medical and health sciences, Double-Blind Method, ResearchInstitutes_Networks_Beacons/lydia_becker_institute_of_immunology_and_inflammation, Internal medicine, cardiac troponin, medicine, Humans, In patient, FEV1, forced expiratory volume in 1 s, Glucocorticoids, Benzyl Alcohols, IQR, interquartile range, Aged, business.industry, Nebulizers and Vaporizers, Troponin I, medicine.disease, HR, hazard ratio, Androstadienes, CI, confidence interval, chemistry, COPD, chronic obstructive pulmonary disease, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a45b7083fe62d2a7d7170897118ae5Test
http://europepmc.org/articles/PMC6119211Test

المؤلفون: Fernando J. Martinez, David E. Newby, Robert D. Brook, Julie C. Yates, Jørgen Vestbo, Courtney Crim, Bartolome R. Celli, Peter M.A. Calverley, Summit investigators, Andrew P. Holmes, Julie A. Anderson, Sally Kilbride

المصدر: Crim, C, Yates, J C, Calverley, P M A, Anderson, J A, Kilbride, S, Holmes, A P, Martinez, F J, Brook, R D, Newby, D E, Celli, B R, Vestbo, J & SUMMIT investigators 2017, ' Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation : The SUMMIT trial ', Respiratory Medicine, vol. 131, pp. 27-34 . https://doi.org/10.1016/j.rmed.2017.07.060Test

مصطلحات موضوعية: Adult, Male, Risk, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Population, Disease, Chlorobenzenes, Placebo, Severity of Illness Index, Fluticasone propionate, Chronic obstructive, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Forced Expiratory Volume, Internal medicine, Administration, Inhalation, medicine, Humans, Corticosteroids, 030212 general & internal medicine, Intensive care medicine, education, Glucocorticoids, Benzyl Alcohols, Aged, Aged, 80 and over, education.field_of_study, COPD, business.industry, Incidence (epidemiology), Pneumonia, Middle Aged, medicine.disease, Bronchodilator Agents, respiratory tract diseases, Androstadienes, Drug Combinations, 030228 respiratory system, chemistry, Female, Vilanterol, Pulmonary disease, business, medicine.drug

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7265ab64422033a6425daf0f8a9d8022Test
https://doi.org/10.1016/j.rmed.2017.07.060Test

المؤلفون: Courtney Crim, Nicholas J. Cowans, Robert D. Brook, Peter M.A. Calverley, Dennis E. Niewoehner, Julie C. Yates, Jørgen Vestbo, Julie A. Anderson, Bartolome R. Celli, David E. Newby, Mark T. Dransfield, Sally Kilbride, Fernando J. Martinez

المصدر: American Journal of Respiratory and Critical Care Medicine. 195:881-888

مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Chlorobenzenes, Critical Care and Intensive Care Medicine, Placebo, Fluticasone propionate, law.invention, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, Adrenal Cortex Hormones, law, Forced Expiratory Volume, Internal medicine, Administration, Inhalation, medicine, Humans, Prospective Studies, 030212 general & internal medicine, Prospective cohort study, Benzyl Alcohols, Aged, COPD, business.industry, Airway obstruction, medicine.disease, Confidence interval, Bronchodilator Agents, Airway Obstruction, Androstadienes, Treatment Outcome, 030228 respiratory system, chemistry, Anesthesia, Female, Vilanterol, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44120e97c974d36110f6a5bf9ba75144Test
https://doi.org/10.1164/rccm.201607-1421ocTest

المؤلفون: Julie A. Anderson, Robert D. Brook, David E. Newby, Julie C. Yates, Jørgen Vestbo, Courtney Crim, Peter M.A. Calverley, Fernando J. Martinez, Bartolome R. Celli

المصدر: Vestbo, J, Anderson, J A, Brook, R D, Calverley, P M A, Celli, B R, Crim, C, Martinez, F, Yates, J & Newby, D E 2016, ' Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT) : A double-blind randomised controlled trial ', The Lancet, vol. 387, no. 10030, pp. 1817-1826 . https://doi.org/10.1016/S0140-6736Test(16)30069-1
2016, ' Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial ', The Lancet, vol. 387, no. 10030, pp. 1817-1826 . https://doi.org/10.1016/S0140-6736Test(16)30069-1

مصطلحات موضوعية: Adult, Male, Vital capacity, medicine.medical_specialty, Population, Placebo, Chlorobenzenes, Fluticasone propionate, law.invention, 03 medical and health sciences, chemistry.chemical_compound, FEV1/FVC ratio, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Risk Factors, Internal medicine, Forced Expiratory Volume, Medicine, Humans, 030212 general & internal medicine, education, Benzyl Alcohols, Aged, Aged, 80 and over, education.field_of_study, COPD, business.industry, General Medicine, Middle Aged, medicine.disease, Bronchodilator Agents, Treatment Outcome, 030228 respiratory system, chemistry, Cardiovascular Diseases, Anesthesia, Fluticasone, Female, Vilanterol, business, medicine.drug

وصف الملف: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d48bb2162e7059ec23b6abcd9b5ce1Test
http://www.scopus.com/inward/record.url?scp=84968779698&partnerID=8YFLogxKTest